These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 32203787)

  • 1. Development of potent inhibitors of the human microsomal epoxide hydrolase.
    Barnych B; Singh N; Negrel S; Zhang Y; Magis D; Roux C; Hua X; Ding Z; Morisseau C; Tantillo DJ; Siegel JB; Hammock BD
    Eur J Med Chem; 2020 May; 193():112206. PubMed ID: 32203787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of microsomal epoxide hydrolases by ureas, amides, and amines.
    Morisseau C; Newman JW; Dowdy DL; Goodrow MH; Hammock BD
    Chem Res Toxicol; 2001 Apr; 14(4):409-15. PubMed ID: 11304129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of metabolically stable inhibitors of Mammalian microsomal epoxide hydrolase.
    Morisseau C; Newman JW; Wheelock CE; Hill Iii T; Morin D; Buckpitt AR; Hammock BD
    Chem Res Toxicol; 2008 Apr; 21(4):951-7. PubMed ID: 18363382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of potent inhibitors of the chicken soluble epoxide hydrolase.
    Shihadih DS; Harris TR; Yang J; Merzlikin O; Lee KS; Hammock BD; Morisseau C
    Bioorg Med Chem Lett; 2015 Jan; 25(2):276-9. PubMed ID: 25479771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of soluble epoxide hydrolase by natural isothiocyanates.
    Elbarbry F; Espiritu MJ; Soo K; Yee B; Taylor J
    Biochem Biophys Res Commun; 2024 Sep; 725():150261. PubMed ID: 38897040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biologically active ester derivatives as potent inhibitors of the soluble epoxide hydrolase.
    Kim IH; Nishi K; Kasagami T; Morisseau C; Liu JY; Tsai HJ; Hammock BD
    Bioorg Med Chem Lett; 2012 Sep; 22(18):5889-92. PubMed ID: 22901393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploring the size of the lipophilic unit of the soluble epoxide hydrolase inhibitors.
    Codony S; Valverde E; Leiva R; Brea J; Isabel Loza M; Morisseau C; Hammock BD; Vázquez S
    Bioorg Med Chem; 2019 Oct; 27(20):115078. PubMed ID: 31488357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of rat liver microsomal epoxide hydrolase by thiazole and pyrazine: hydrolysis of 2-cyanoethylene oxide.
    Kim SG; Kedderis GL; Batra R; Novak RF
    Carcinogenesis; 1993 Aug; 14(8):1665-70. PubMed ID: 7689039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of soluble and microsomal epoxide hydrolase by zinc and other metals.
    Draper AJ; Hammock BD
    Toxicol Sci; 1999 Nov; 52(1):26-32. PubMed ID: 10568695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of fluorescent substrates for microsomal epoxide hydrolase and application to inhibition studies.
    Morisseau C; Bernay M; Escaich A; Sanborn JR; Lango J; Hammock BD
    Anal Biochem; 2011 Jul; 414(1):154-62. PubMed ID: 21371418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure activity relationship of human microsomal epoxide hydrolase inhibition by amide and acid analogues of valproic acid.
    Spiegelstein O; Kroetz DL; Levy RH; Yagen B; Hurst SI; Levi M; Haj-Yehia A; Bialer M
    Pharm Res; 2000 Feb; 17(2):216-21. PubMed ID: 10751038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin and glucagon signaling in regulation of microsomal epoxide hydrolase expression in primary cultured rat hepatocytes.
    Kim SK; Woodcroft KJ; Kim SG; Novak RF
    Drug Metab Dispos; 2003 Oct; 31(10):1260-8. PubMed ID: 12975336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-activity relationships of amide-phosphonate derivatives as inhibitors of the human soluble epoxide hydrolase.
    Kim IH; Park YK; Nishiwaki H; Hammock BD; Nishi K
    Bioorg Med Chem; 2015 Nov; 23(22):7199-210. PubMed ID: 26507430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble epoxide hydrolase inhibitors with carboranes as non-natural 3-D pharmacophores.
    Scholz MS; Wingen LM; Brunst S; Wittmann SK; Cardoso ILA; Weizel L; Proschak E
    Eur J Med Chem; 2020 Jan; 185():111766. PubMed ID: 31677445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel amide derivatives of 3-phenylglutaric acid as potent soluble epoxide hydrolase inhibitors.
    Rezaee E; Amrolah SM; Nazari M; Tabatabai SA
    Mol Divers; 2021 Feb; 25(1):45-53. PubMed ID: 31873869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic detoxification: implications for thresholds.
    Oesch F; Herrero ME; Hengstler JG; Lohmann M; Arand M
    Toxicol Pathol; 2000; 28(3):382-7. PubMed ID: 10862554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Further exploration of the structure-activity relationship of dual soluble epoxide hydrolase/fatty acid amide hydrolase inhibitors.
    Wilt S; Kodani S; Valencia L; Hudson PK; Sanchez S; Quintana T; Morisseau C; Hammock BD; Kandasamy R; Pecic S
    Bioorg Med Chem; 2021 Dec; 51():116507. PubMed ID: 34794001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic enhancement of microsomal epoxide hydrolase improves metabolic detoxification but impairs cerebral blood flow regulation.
    Marowsky A; Haenel K; Bockamp E; Heck R; Rutishauser S; Mule N; Kindler D; Rudin M; Arand M
    Arch Toxicol; 2016 Dec; 90(12):3017-3027. PubMed ID: 26838043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of phthalimide derivatives as novel inhibitors of a soluble epoxide hydrolase.
    Mahlooji I; Shokri M; Manoochehri R; Mahboubi-Rabbani M; Rezaee E; Tabatabai SA
    Arch Pharm (Weinheim); 2020 Aug; 353(8):e2000052. PubMed ID: 32484272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential induction of rat hepatic microsomal epoxide hydrolase and rGSTA2 by diazines: the role of cytochrome P450 2E1-mediated metabolic activation.
    Cho MK; Kim SG
    Chem Biol Interact; 1998 Nov; 116(3):229-45. PubMed ID: 9920464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.